Cargando…

Case Report: Guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited renal disease characterized by the bilateral development of multiple cysts in the kidneys. Pain management is a clinically important issue, especially because approximately 60% of patients with ADPKD experience chronic pain related...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasahara, Satoshi, Kanda, Shoichiro, Takahashi, Miwako, Fujioka, Mao, Morita, Taito, Matsudaira, Ko, Sato, Naoko, Hattori, Motoshi, Momose, Toshimitsu, Niwa, Shin-Ichi, Uchida, Kanji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646415/
https://www.ncbi.nlm.nih.gov/pubmed/38027301
http://dx.doi.org/10.3389/fped.2023.1283823
_version_ 1785134890298114048
author Kasahara, Satoshi
Kanda, Shoichiro
Takahashi, Miwako
Fujioka, Mao
Morita, Taito
Matsudaira, Ko
Sato, Naoko
Hattori, Motoshi
Momose, Toshimitsu
Niwa, Shin-Ichi
Uchida, Kanji
author_facet Kasahara, Satoshi
Kanda, Shoichiro
Takahashi, Miwako
Fujioka, Mao
Morita, Taito
Matsudaira, Ko
Sato, Naoko
Hattori, Motoshi
Momose, Toshimitsu
Niwa, Shin-Ichi
Uchida, Kanji
author_sort Kasahara, Satoshi
collection PubMed
description Autosomal dominant polycystic kidney disease (ADPKD) is an inherited renal disease characterized by the bilateral development of multiple cysts in the kidneys. Pain management is a clinically important issue, especially because approximately 60% of patients with ADPKD experience chronic pain related to hemorrhage from renal cysts, which significantly reduces their daily life. The cystic fibrosis transmembrane conductance regulator, the molecule responsible for cyst formation in ADPKD, is also the cause of cystic fibrosis. Since attention deficit hyperactivity disorder (ADHD) is known to occur frequently in conjunction with cystic fibrosis, ADPKD may be associated with ADHD. However, to our knowledge, no study has investigated 1) ADHD or autism spectrum disorder (ASD) as comorbidities with ADPKD, 2) the effects of ADHD medications on chronic pain in ADPKD, or 3) cerebral blood flow corresponding to guanfacine (GF) or methylphenidate (MP) treatment for chronic pain. We report the case of a 15-year-old girl with ADPKD, who had chronic back pain associated with ADPKD and had to withdraw from high school because the pain interfered with her daily life. Although she took antihypertensive medications to prevent bleeding, they did not provide adequate blood pressure control. The patient was referred to a child psychiatrist and diagnosed with ASD; however, the pain did not improve. Subsequently, she was referred to our pain center. The diagnosis of ADHD was confirmed and treatment with ADHD medications was initiated. Monotherapy with MP, atomoxetine, and GF resulted in hypertension and hypotension as side effects; however, a combination of MP 18 mg and GF 4 mg provided pain relief and moderate blood pressure control, and the patient was able to go on to college. During the course of treatment, there was an improvement in the distribution of cerebral blood flow in the prefrontal and insular cortices. Confirmation of an ADHD diagnosis comorbid with ASD enabled the use of ADHD medications. The combination of MP and GF improved chronic back pain and high blood pressure due to ADPKD and cerebral blood flow. Screening for ADHD is important in the treatment of ADPKD.
format Online
Article
Text
id pubmed-10646415
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106464152023-11-01 Case Report: Guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder Kasahara, Satoshi Kanda, Shoichiro Takahashi, Miwako Fujioka, Mao Morita, Taito Matsudaira, Ko Sato, Naoko Hattori, Motoshi Momose, Toshimitsu Niwa, Shin-Ichi Uchida, Kanji Front Pediatr Pediatrics Autosomal dominant polycystic kidney disease (ADPKD) is an inherited renal disease characterized by the bilateral development of multiple cysts in the kidneys. Pain management is a clinically important issue, especially because approximately 60% of patients with ADPKD experience chronic pain related to hemorrhage from renal cysts, which significantly reduces their daily life. The cystic fibrosis transmembrane conductance regulator, the molecule responsible for cyst formation in ADPKD, is also the cause of cystic fibrosis. Since attention deficit hyperactivity disorder (ADHD) is known to occur frequently in conjunction with cystic fibrosis, ADPKD may be associated with ADHD. However, to our knowledge, no study has investigated 1) ADHD or autism spectrum disorder (ASD) as comorbidities with ADPKD, 2) the effects of ADHD medications on chronic pain in ADPKD, or 3) cerebral blood flow corresponding to guanfacine (GF) or methylphenidate (MP) treatment for chronic pain. We report the case of a 15-year-old girl with ADPKD, who had chronic back pain associated with ADPKD and had to withdraw from high school because the pain interfered with her daily life. Although she took antihypertensive medications to prevent bleeding, they did not provide adequate blood pressure control. The patient was referred to a child psychiatrist and diagnosed with ASD; however, the pain did not improve. Subsequently, she was referred to our pain center. The diagnosis of ADHD was confirmed and treatment with ADHD medications was initiated. Monotherapy with MP, atomoxetine, and GF resulted in hypertension and hypotension as side effects; however, a combination of MP 18 mg and GF 4 mg provided pain relief and moderate blood pressure control, and the patient was able to go on to college. During the course of treatment, there was an improvement in the distribution of cerebral blood flow in the prefrontal and insular cortices. Confirmation of an ADHD diagnosis comorbid with ASD enabled the use of ADHD medications. The combination of MP and GF improved chronic back pain and high blood pressure due to ADPKD and cerebral blood flow. Screening for ADHD is important in the treatment of ADPKD. Frontiers Media S.A. 2023-11-01 /pmc/articles/PMC10646415/ /pubmed/38027301 http://dx.doi.org/10.3389/fped.2023.1283823 Text en © 2023 Kasahara, Kanda, Takahashi, Fujioka, Morita, Matsudaira, Sato, Hattori, Momose, Niwa and Uchida. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Kasahara, Satoshi
Kanda, Shoichiro
Takahashi, Miwako
Fujioka, Mao
Morita, Taito
Matsudaira, Ko
Sato, Naoko
Hattori, Motoshi
Momose, Toshimitsu
Niwa, Shin-Ichi
Uchida, Kanji
Case Report: Guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder
title Case Report: Guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder
title_full Case Report: Guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder
title_fullStr Case Report: Guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder
title_full_unstemmed Case Report: Guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder
title_short Case Report: Guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder
title_sort case report: guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646415/
https://www.ncbi.nlm.nih.gov/pubmed/38027301
http://dx.doi.org/10.3389/fped.2023.1283823
work_keys_str_mv AT kasaharasatoshi casereportguanfacineandmethylphenidateimprovedchroniclowerbackpaininautosomaldominantpolycystickidneydiseasewithcomorbidattentiondeficithyperactivitydisorderandautismspectrumdisorder
AT kandashoichiro casereportguanfacineandmethylphenidateimprovedchroniclowerbackpaininautosomaldominantpolycystickidneydiseasewithcomorbidattentiondeficithyperactivitydisorderandautismspectrumdisorder
AT takahashimiwako casereportguanfacineandmethylphenidateimprovedchroniclowerbackpaininautosomaldominantpolycystickidneydiseasewithcomorbidattentiondeficithyperactivitydisorderandautismspectrumdisorder
AT fujiokamao casereportguanfacineandmethylphenidateimprovedchroniclowerbackpaininautosomaldominantpolycystickidneydiseasewithcomorbidattentiondeficithyperactivitydisorderandautismspectrumdisorder
AT moritataito casereportguanfacineandmethylphenidateimprovedchroniclowerbackpaininautosomaldominantpolycystickidneydiseasewithcomorbidattentiondeficithyperactivitydisorderandautismspectrumdisorder
AT matsudairako casereportguanfacineandmethylphenidateimprovedchroniclowerbackpaininautosomaldominantpolycystickidneydiseasewithcomorbidattentiondeficithyperactivitydisorderandautismspectrumdisorder
AT satonaoko casereportguanfacineandmethylphenidateimprovedchroniclowerbackpaininautosomaldominantpolycystickidneydiseasewithcomorbidattentiondeficithyperactivitydisorderandautismspectrumdisorder
AT hattorimotoshi casereportguanfacineandmethylphenidateimprovedchroniclowerbackpaininautosomaldominantpolycystickidneydiseasewithcomorbidattentiondeficithyperactivitydisorderandautismspectrumdisorder
AT momosetoshimitsu casereportguanfacineandmethylphenidateimprovedchroniclowerbackpaininautosomaldominantpolycystickidneydiseasewithcomorbidattentiondeficithyperactivitydisorderandautismspectrumdisorder
AT niwashinichi casereportguanfacineandmethylphenidateimprovedchroniclowerbackpaininautosomaldominantpolycystickidneydiseasewithcomorbidattentiondeficithyperactivitydisorderandautismspectrumdisorder
AT uchidakanji casereportguanfacineandmethylphenidateimprovedchroniclowerbackpaininautosomaldominantpolycystickidneydiseasewithcomorbidattentiondeficithyperactivitydisorderandautismspectrumdisorder